JTCS Sign the Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Hans-Beat Ris
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vallet, C.
Right arrow Articles by Ris, H.-B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vallet, C.
Right arrow Articles by Ris, H.-B.
Related Collections
Right arrow Pleura

J Thorac Cardiovasc Surg 2004;127:1511-1513
© 2004 The American Association for Thoracic Surgery


Brief communication

Stage III empyema caused by Actinomyces meyeri: A plea for decortication

Cédric Valleta,*, Edgardo Pezzettaa, Geneviève Nicolet-Chatelinb, Zihad El Lamaab, Olivier Martineta, Hans-Beat Risa

a Department ofThoracic and Vascular Surgery University Hospital, Lausanne, Switzerland
b Department of Pulmonary Medicine, University Hospital, Lausanne, Switzerland

Received for publication October 7, 2003; revisions received November 4, 2003; * Address for reprints: Cédric Vallet, Department of Thoracic and Vascular Surgery, University Hospital, Rue du Bugnon 46, CH-1011 Lausanne, Switzerland
cvallet{at}hospvd.ch


Dr Vallet


Actinomycosis is a rare infectious disease caused by Actinomyces species, a genus of anaerobic gram-positive bacillus. Actinomyces organisms are saprophytes of the human digestive tract and are very sensitive to penicillin. Thoracic actinomycosis represents 15% to 20% of cases1-4 with pleural effusion in only 20% of intrathoracic affection.1,4,5 The usual clinical picture is that of a pleural effusion or pleural empyema together with a parenchymatous infection. We report a case of pleural effusion caused by Actinomyces meyeri without pulmonary involvement that failed to respond to chest tube drainage and antibiotherapy.

Clinical summary

A 64-year-old woman was admitted with a history of fever and a dry cough associated with asthenia, weight loss, and exertional dyspnea. There was no previous medical history except for smoking and alcohol abuse. Laboratory studies showed a hemoglobin value of 9.9 g/100 mL, a hematocrit value of 25%, a leukocyte count of 13,200/mm3, and a sedimentation rate of greater than 120 mm/h. Hemocultures were sterile, and the result of an HIV test was negative. A chest radiograph showed a massive left pleural effusion (Figure 1). Chest tube drainage was performed, and this revealed a purulent effusion. A meyeri was identified after culture of the pleural effusion. Despite treatment with intravenous penicillin (20 Mio IU/d), a loculated pleural effusion developed. Chest computed tomography (CT) demonstrated thickening and enhancement of the parietal pleura and confirmed loculation of pleural effusion and left lower lobe atelectasis (Figure 2). Bronchial carcinoma was excluded by means of bronchoscopy and transbronchial biopsy of the left lower lobe. Pulmonary function testing revealed moderated obstruction and an important restriction, with a forced expiratory volume in 1 second of 1.04 L (47% of predicted value), a forced vital capacity of 1.72 L (66% of predicted value), and a total lung capacity of 3.58 L (72% of predicted value). The patient remained febrile without clinical improvement and complained of pain at the site of previous drainage. A stage III empyema was diagnosed, and an operation was performed.



View larger version (139K):
[in this window]
[in a new window]
 
Figure 1. Chest radiograph showing pleural effusion related to A meyeri.

 


View larger version (114K):
[in this window]
[in a new window]
 
Figure 2. Chest CT scan showing loculated effusion, pleural enhancement, and atelectasis of the left lower lobe without signs of parenchymal actinomycosis.

 
At thoracotomy, we found a pleurosubcutaneous fistula at the site of thoracic drainage mimicking an empyema necessitatis. The parietal and visceral pleura were thickened and adherent to adjacent structures, as usually seen in advanced mesothelioma. Decortication was performed with resection of the sinus tract, including the sixth rib and its interspace. Microbiologic examination of the pleura was performed, and A meyeri was found in the pleural loculations filled with putrid liquid. The patient presented no postoperative complication and was discharged after 16 days. An oral penicillin regimen was prescribed for 6 months. Clinical and radiologic evolutions were favorable, with minimal pleural sequellae on chest radiography. Functional evaluation at 6 months after the operation revealed a forced expiratory volume in 1 second of 1.49 L (68% of predicted value) and a forced vital capacity of 2.52 L (96% of predicted value). The patient gained weight, and thoracic pain disappeared. Fiberoptic bronchoscopy 7 months after the operation revealed a benign fibroepithelial polyp at the origin of the lower lobe bronchus that was resected with biopsy forceps. Bacteriologic cultures of bronchial aspiration remained sterile.

Discussion

The genus Actinomyces consists of gram-positive, non–acid-fast, nonmotile organisms that never produce spores and usually require an anaerobic environment for growth. Actinomyces organisms are considered bacteria because of their cell-wall component and susceptibility to antibacterial drugs, such as penicillin.6 Actinomycosis is a chronic, suppurative granulomatous infection. It typically involves cervicofacial and abdominopelvic organs. Thoracic involvement is less frequent.

Actinomyces species are commensals of the human oropharynx, gastrointestinal tract, and female genitalia and are often routinely cultured from these mucosa-lined orifices. Fourteen species have been characterized to date.7 Six of these are thought to be pathogenic in human subjects, including Actinomyces israelii, Actinomyces neslundi, Actinomyces odontolyticus, Actinomyces viscosus, A meyeri, and Actinomyces gerencseriae, and A israelli is the organism most commonly incriminated in human disease. In contrast to other species, A meyeri might have a greater tendency of affecting the lung and hematogenous dissemination. A meyeri is an obligatory anaerobe organism that can be distinguished from other Actinomyces species on the basis of colony morphologic aspects, biochemical tests, acid production, end products from sugars, and cell-wall peptidoglycan analysis.6 These microorganisms might become pathogenic in debilitated patients who abuse alcohol and have bad oral hygiene. Infection is prevalent in men aged 30 to 50 years.2,3,8

A crucial step in the development of clinical manifestation of the disease is the disruption of the mucosal barrier, allowing the organisms to invade. Pulmonary infection usually occurs after bronchial aspiration of oropharyngeal or gastrointestinal contents and rarely after an esophageal injury or by means of hematogenous spread. Pleural actinomycosis starts as a bronchopulmonary disease and involves the pleura through lymphatic spread.9 Aspiration of saliva or other material containing Actinomyces species might then cause atelectasis and pneumonitis. The initial acute inflammation is followed by the characteristic chronic and indolent phase of the disease that generates abscesses, necrosis, and fibrosis of lung parenchyma, which commonly cavitates. It progresses slowly without respecting anatomic boundaries, such as interlobar fissures or the chest wall. If not recognized, the parenchymal disease invades the pleura, the chest wall, soft tissues, and bony structures. Sinus tract formation and empyema necessitatis might arise, causing purulent discharge with yellowish sulfur granules.10 In our patient the sinus tract followed the chest tube into the subcutaneous tissue at the time of the operation, with imminent fistulization of the skin.

Clinical features are nonspecific and similar to those of other chronic suppurative chest diseases. Physical signs are equally nonspecific except in advanced and untreated disease, during which fistulization might be seen.

Imaging is useful in evaluating the extent and chronicity of disease. Definitive diagnosis is confirmed by means of histologic or microbiologic examination confirmation. Plain chest radiograph findings in actinomycosis are nonspecific. CT is more helpful in providing information on parenchymal involvement and extension into the adjacent chest wall. Pleural effusion with or without pleural thickening might also be diagnosed on the basis of CT scans.

Compared with pulmonary actinomycosis, the bacteriologic diagnosis is easily obtained by means of thoracocentesis in case of pleural involvement. However, diagnosis might be obscured by previous antibiotic therapy and a lack of anaerobic conditions for culture. At direct microbiologic examination, actinomycosis has to be suspected if gram-positive filamentous germs are discovered. An anaerobic enriched environment is needed for appropriate culture.

Penicillin G still remains the drug of choice, and the mainstay of treatment is the administration of high-dose intravenous penicillin. Eighteen to 24 millions units of penicillin per day are given for 2 to 6 weeks, followed by oral penicillin V administration for another 6 to 12 months. The evolution should be monitored by use of plain radiographs or CT.

In stage I empyema, indication for surgical intervention is uncommon, but the efficacy of antibiotic therapy depends on the onset of diagnosis. If the treatment is delayed, stage II and III empyemas can develop, and decortication is required. Chest-wall fistulization has to be resected during the intervention. A VATS approach is usually unrewarding because of the chronicity of empyema at the time of the operation. After the operation, penicillin administration is recommended.

References

  1. Bates M. Thoracic actinomycosis. Thorax. 1957;12:99–124
  2. Benhoff D. Actinomycosis: diagnostic and therapeutic considerations and review of 32 cases. Laryngoscope. 1984;94:1198–1217[Medline]
  3. Brown JR. Human actinomycosis. A study of 181 subjects. Hum Pathol. 1973;4:319–330[Medline]
  4. Mabeza G, Macfarlane J. Pulmonary actinomycosis. Eur Respir J. 2003;21:545–551[Abstract/Free Full Text]
  5. Hsieh MJ, Liu HP, Chang JP, Chang CH. Thoracic actinomycosis. Chest. 1993;104:366–370[Abstract/Free Full Text]
  6. Rose HD, Varkey B, Kutty CP. Thoracic actinomycosis caused by Actinomyces meyeri. Am Rev Respir Dis. 1982;125:251–254[Medline]
  7. Smego R, Foglia G. Actinomycosis. Clin Infect Dis. 1998;26:1255–1263[Medline]
  8. Weese W, Smith I. A study of 57 cases of actinomycosis over a 36 year period. Arch Intern Med. 1975;135:562–568
  9. Touboul JL, Chaussade F, Desvignes B, Mangeney T, Bidault C. Isolated pleural actinomycosis. A propos of 2 cases. Rev Pneumol Clin. 1990;46:69–72[Medline]
  10. Hooker TP, Hammond M, Corral K. Empyema necessitatis: review of the manifestations of thoracic actinomycosis. Cleve Clin J Med. 1992;59:542–548[Medline]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Hans-Beat Ris
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vallet, C.
Right arrow Articles by Ris, H.-B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vallet, C.
Right arrow Articles by Ris, H.-B.
Related Collections
Right arrow Pleura


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS